INDIA |NSE |INR
Shares Outstanding | 40.67M | Beta | 1.25 |
---|---|---|---|
Public Float | 14.28M | P/E Ratio | - |
% Short of Float | - | Dividend (Yield) | 0.25 (0.00%) |
Held by Insiders | 33.91% | Ex-Dividend Date | Sep 15, 2021 |
Held by Institutions | - | IPO Date | - |
Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|
Revenue | INR1.37B | INR2.02B | INR1.67B |
EBITDA | INR78.30M | INR472.79M | INR293.71M |
Net Income | INR-53.67M | INR227.78M | INR36.28M |
Total Assets | INR1.99B | INR2.08B | INR2.32B |
Total Cash | INR110.41M | INR38.39M | INR25.68M |
Total Debt | INR | INR | INR484.94M |
Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|
Revenue | INR512.12M | INR157.37M | INR341.11M |
EBITDA | INR31.30M | INR-11.82M | INR12.54M |
Net Income | INR122.84M | INR-47.14M | INR-137.44M |
Total Assets | INR1.99B | INR | INR1.98B |
Total Cash | INR110.41M | INR | INR5.83M |
Total Debt | INR | INR | INR262.00K |
Year | Open | Close | Change |
---|---|---|---|
2021 | INR70.00 | INR63.00 | -10.00% |
2021 | INR85.75 | INR70.00 | -18.37% |
2020 | INR17.20 | INR85.75 | 398.55% |
Date | Open | High | Low | Close | Change | Volume |
---|---|---|---|---|---|---|
Jun 17, 2022 | INR35.15 | INR35.95 | INR33.80 | INR34.30 | -9.26% | 108.22K |
Jun 14, 2022 | INR39.20 | INR39.20 | INR37.55 | INR37.80 | -8.70% | 85.55K |
Jun 9, 2022 | INR41.10 | INR42.50 | INR41.10 | INR41.40 | -0.60% | 41.67K |
Last quarter (ended on March 31 ,2022) Lasa supergenerics generated a net income of INR122.84M, representing a 69.08% decrease compared to the same quarter a year before (ended on March 31 ,2021).
Last fiscal year (ended on March 31 ,2022) Lasa supergenerics generated a net income of INR-53.67M, representing a 123.56% decrease compare to the previous fiscal year (ended on March 31 ,2021).
View More Details on Lasa supergenerics's “Financials” Section
Lasa supergenerics trades on the NSE stock market in India under the ticker symbol "LASA". Lasa supergenerics’s stock symbol can also be displayed as "NSE:LASA".
Lasa supergenerics (NSE:LASA) is owned by 0.00% institutional shareholders and by 33.91% insiders. The rest is owned by the public.
Explore More Details on Lasa supergenerics's “Ownership” Section
Lasa supergenerics's key executive team includes the following managers:
Lasa supergenerics (NSE:LASA) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.
Currently the number of employees working for Lasa supergenerics is 0.
Lasa supergenerics (NSE:LASA) is headquartered in India.
Lasa supergenerics’s mailing address is 02 Commercial Tower, Mumbai, India, 400080.
The company’s phone number is 91 22 4970 1092.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.